Skip to main content
Top
Published in: Forensic Science, Medicine and Pathology 4/2019

01-12-2019 | Secondary Immunodeficiency | Case Report

Immunodeficiency as a side effect of anabolic androgenic steroid abuse: a case of necrotizing myofasciitis

Authors: Giuseppe Bertozzi, Francesco Sessa, Francesca Maglietta, Luigi Cipolloni, Monica Salerno, Carmela Fiore, Palmira Fortarezza, Pietrantonio Ricci, Emanuela Turillazzi, Cristoforo Pomara

Published in: Forensic Science, Medicine and Pathology | Issue 4/2019

Login to get access

Abstract

Even if there are well-known consequences of anabolic androgenic steroid (AAS) abuse, their full pathway of action is still being investigated. In this context, the presented case report aims to discuss and provide evidence of unusual adverse effects linked to immunodeficiency in an AAS abuser. In fact, this kind of chronic complication, even if not usually considered, may lead sudden death. In this case a 31-year-old aesthetic weightlifter, who presented to the emergency department due to an accidental fall that resulted in left thigh trauma. This subsequently developed into left thigh necrotizing myofasciitis in the following few days. Although surgery and hyperbaric therapy were carried out, the man died. An autopsy with complete biological sampling for toxicological studies was performed. This case highlights the close relationship between AAS abuse and immunodeficiency and highlights it’s importance for further studies. However, it should be considered that of all the dangerous effects produced by AAS use, necrotizing fasciitis is not such an unusual consequence.
Literature
1.
go back to reference Nieschlag E, Vorona E. Doping with anabolic androgenic steroids (AAS): adverse effects on non-reproductive organs and functions. Rev Endocr Metab Disord. 2015;16:199–211.CrossRef Nieschlag E, Vorona E. Doping with anabolic androgenic steroids (AAS): adverse effects on non-reproductive organs and functions. Rev Endocr Metab Disord. 2015;16:199–211.CrossRef
2.
go back to reference Piacentino D, Kotzalidis GD, del Casale A, Aromatario MR, Pomara C, Girardi P, et al. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol. 2015;13:101–21.CrossRef Piacentino D, Kotzalidis GD, del Casale A, Aromatario MR, Pomara C, Girardi P, et al. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol. 2015;13:101–21.CrossRef
3.
go back to reference Frati P, Busardò FP, Cipolloni L, De Dominicis E, Fineschi V. Anabolic androgenic steroid (AAS) related deaths: Autoptic, histopathological and toxicological findings. Curr Neuropharmacol. 2015;13:146–59.CrossRef Frati P, Busardò FP, Cipolloni L, De Dominicis E, Fineschi V. Anabolic androgenic steroid (AAS) related deaths: Autoptic, histopathological and toxicological findings. Curr Neuropharmacol. 2015;13:146–59.CrossRef
4.
go back to reference Albano GD, Sessa F, Messina A, Monda V, Bertozzi G, Maglietta F, et al. AAS and organs damage: a focus on Nandrolone effects. Acta Medica Mediterr. 2017;2017:939–46. Albano GD, Sessa F, Messina A, Monda V, Bertozzi G, Maglietta F, et al. AAS and organs damage: a focus on Nandrolone effects. Acta Medica Mediterr. 2017;2017:939–46.
6.
go back to reference Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24:383–98.CrossRef Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24:383–98.CrossRef
7.
go back to reference Börjesson A, Gårevik N, Dahl ML, Rane A, Ekström L. Recruitment to doping and help-seeking behavior of eight female AAS users. Subst Abus Treat Prev Policy. 2016;11:11.CrossRef Börjesson A, Gårevik N, Dahl ML, Rane A, Ekström L. Recruitment to doping and help-seeking behavior of eight female AAS users. Subst Abus Treat Prev Policy. 2016;11:11.CrossRef
8.
go back to reference Ip EJ, Barnett MJ, Tenerowicz MJ, Kim JA, Wei H, Perry PJ. Women and anabolic steroids: an analysis of a dozen users. Clin J Sport Med. 2010;20:475–81.CrossRef Ip EJ, Barnett MJ, Tenerowicz MJ, Kim JA, Wei H, Perry PJ. Women and anabolic steroids: an analysis of a dozen users. Clin J Sport Med. 2010;20:475–81.CrossRef
9.
go back to reference Sessa F, Franco S, Picciocchi E, Geraci D, Chisari MG, Marsala G, et al. Forensic considerations on violent parasomnias during lifespan. Acta Medica Mediterr. 2018;34(Special Is):2135–42. Sessa F, Franco S, Picciocchi E, Geraci D, Chisari MG, Marsala G, et al. Forensic considerations on violent parasomnias during lifespan. Acta Medica Mediterr. 2018;34(Special Is):2135–42.
10.
go back to reference Abrahin O, Félix Souza NS, de Sousa EC, Santos AM, Bahrke MS. Anabolic–androgenic steroid use among Brazilian women: an exploratory investigation. J Subst Use. 2017;22:246–52.CrossRef Abrahin O, Félix Souza NS, de Sousa EC, Santos AM, Bahrke MS. Anabolic–androgenic steroid use among Brazilian women: an exploratory investigation. J Subst Use. 2017;22:246–52.CrossRef
11.
go back to reference Salerno M, Cascio O, Bertozzi G, Sessa F, Messina A, Monda V, et al. Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review. Oncotarget. 2018;9:19415–26.CrossRef Salerno M, Cascio O, Bertozzi G, Sessa F, Messina A, Monda V, et al. Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review. Oncotarget. 2018;9:19415–26.CrossRef
12.
go back to reference Bertozzi G, Sessa F, Albano GD, Sani G, Maglietta F, Roshan MHK, et al. The role of anabolic androgenic steroids in disruption of the physiological function in discrete areas of the central nervous system. Mol Neurobiol. 2018;55:5548–56.CrossRef Bertozzi G, Sessa F, Albano GD, Sani G, Maglietta F, Roshan MHK, et al. The role of anabolic androgenic steroids in disruption of the physiological function in discrete areas of the central nervous system. Mol Neurobiol. 2018;55:5548–56.CrossRef
13.
go back to reference Pomara C, Barone R, Marino Gammazza A, Sangiorgi C, Barone F, Pitruzzella A, et al. Effects of nandrolone stimulation on testosterone biosynthesis in Leydig cells. J Cell Physiol. 2016;231:1385–91.CrossRef Pomara C, Barone R, Marino Gammazza A, Sangiorgi C, Barone F, Pitruzzella A, et al. Effects of nandrolone stimulation on testosterone biosynthesis in Leydig cells. J Cell Physiol. 2016;231:1385–91.CrossRef
14.
go back to reference Sessa F, Anna V, Messina G, Cibelli G, Monda V, Marsala G, et al. Heart rate variability as predictive factor for sudden cardiac death. Aging. 2018;10:166–77.CrossRef Sessa F, Anna V, Messina G, Cibelli G, Monda V, Marsala G, et al. Heart rate variability as predictive factor for sudden cardiac death. Aging. 2018;10:166–77.CrossRef
15.
go back to reference Sessa F, Chetta M, Petito A, Franzetti M, Bafunno V, Pisanelli D, et al. Gene polymorphisms and sport attitude in Italian athletes. Genet Test Mol Biomarkers. 2011;15:285–90.CrossRef Sessa F, Chetta M, Petito A, Franzetti M, Bafunno V, Pisanelli D, et al. Gene polymorphisms and sport attitude in Italian athletes. Genet Test Mol Biomarkers. 2011;15:285–90.CrossRef
16.
go back to reference Willems SM, Wright DJ, Day FR, Trajanoska K, Joshi PK, Morris JA, et al. Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness. Nat Commun. 2017;8:16015.CrossRef Willems SM, Wright DJ, Day FR, Trajanoska K, Joshi PK, Morris JA, et al. Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness. Nat Commun. 2017;8:16015.CrossRef
17.
go back to reference Petito A, Altamura M, Iuso S, Padalino FA, Sessa F, D’Andrea G, et al. The relationship between personality traits, the 5HTT polymorphisms, and the occurrence of anxiety and depressive symptoms in elite athletes. PLoS One. 2016;11:e0156601.CrossRef Petito A, Altamura M, Iuso S, Padalino FA, Sessa F, D’Andrea G, et al. The relationship between personality traits, the 5HTT polymorphisms, and the occurrence of anxiety and depressive symptoms in elite athletes. PLoS One. 2016;11:e0156601.CrossRef
18.
go back to reference Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38:644–51.CrossRef Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38:644–51.CrossRef
19.
go back to reference Antonopoulos GA, Hall A. ‘Gain with no pain’: anabolic-androgenic steroids trafficking in the UK. Eur J Criminol. 2016;13:696–713.CrossRef Antonopoulos GA, Hall A. ‘Gain with no pain’: anabolic-androgenic steroids trafficking in the UK. Eur J Criminol. 2016;13:696–713.CrossRef
20.
go back to reference da Justa Neves DB, Marcheti RGA, Caldas ED. Incidence of anabolic steroid counterfeiting in Brazil. Forensic Sci Int. 2013;228:e81–3.CrossRef da Justa Neves DB, Marcheti RGA, Caldas ED. Incidence of anabolic steroid counterfeiting in Brazil. Forensic Sci Int. 2013;228:e81–3.CrossRef
21.
go back to reference Krug O, Thomas A, Walpurgis K, Piper T, Sigmund G, Schänzer W, et al. Identification of black market products and potential doping agents in Germany 2010-2013. Eur J Clin Pharmacol. 2014;70:1303–11.CrossRef Krug O, Thomas A, Walpurgis K, Piper T, Sigmund G, Schänzer W, et al. Identification of black market products and potential doping agents in Germany 2010-2013. Eur J Clin Pharmacol. 2014;70:1303–11.CrossRef
22.
go back to reference Chatwin C, Measham F, O’Brien K, Sumnall H. New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs. Int J Drug Policy. 2017;40:1–5.CrossRef Chatwin C, Measham F, O’Brien K, Sumnall H. New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs. Int J Drug Policy. 2017;40:1–5.CrossRef
23.
go back to reference Sessa F, Messina G, Valenzano A, Messina A, Salerno M, Marsala G, et al. Sports training and adaptive changes. Sport Sci Health. 2018;3:705–8.CrossRef Sessa F, Messina G, Valenzano A, Messina A, Salerno M, Marsala G, et al. Sports training and adaptive changes. Sport Sci Health. 2018;3:705–8.CrossRef
24.
go back to reference Nieschlag E, Vorona E. Mechanisms in endocrinology: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173:R47–58.CrossRef Nieschlag E, Vorona E. Mechanisms in endocrinology: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173:R47–58.CrossRef
25.
go back to reference Sagoe D, McVeigh J, Bjørnebekk A, Essilfie MS, Andreassen CS, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abus Treat Prev Policy. 2015;10:12.CrossRef Sagoe D, McVeigh J, Bjørnebekk A, Essilfie MS, Andreassen CS, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abus Treat Prev Policy. 2015;10:12.CrossRef
27.
go back to reference Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Jt Surg - Ser A. 2003;85:1454–60.CrossRef Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Jt Surg - Ser A. 2003;85:1454–60.CrossRef
28.
go back to reference Grant S, Dearing J, Ghosh S, Collier A, Bal AM. Necrotizing myositis of the deltoid following intramuscular injection of anabolic steroid. Int J Infect Dis. 2010;14:e823–4.CrossRef Grant S, Dearing J, Ghosh S, Collier A, Bal AM. Necrotizing myositis of the deltoid following intramuscular injection of anabolic steroid. Int J Infect Dis. 2010;14:e823–4.CrossRef
29.
go back to reference Hughes M, Ahmed S. Anabolic androgenic steroid induced necrotising myopathy. Rheumatol Int. 2011;31:915–7.CrossRef Hughes M, Ahmed S. Anabolic androgenic steroid induced necrotising myopathy. Rheumatol Int. 2011;31:915–7.CrossRef
30.
go back to reference Souza N, Filho C, Figueirido Gaspar E, Siqueira KL, Monteiro GC, Andreoli CV, et al. Pyomyositis in athletes after use of anabolic steroids - case reports. Soc Bras Ortop e Traumatol. 2011;46:97–100. Souza N, Filho C, Figueirido Gaspar E, Siqueira KL, Monteiro GC, Andreoli CV, et al. Pyomyositis in athletes after use of anabolic steroids - case reports. Soc Bras Ortop e Traumatol. 2011;46:97–100.
31.
go back to reference Choi SM, Lee B-M. Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids. Expert Opin Drug Saf. 2015;14:1773–85.CrossRef Choi SM, Lee B-M. Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids. Expert Opin Drug Saf. 2015;14:1773–85.CrossRef
32.
go back to reference Brenu EW, McNaughton L, Marshall-Gradisnik SM. Is there a potential immune dysfunction with anabolic androgenic steroid use?: a review. Mini-Reviews Med Chem. 2011;11:438–45.CrossRef Brenu EW, McNaughton L, Marshall-Gradisnik SM. Is there a potential immune dysfunction with anabolic androgenic steroid use?: a review. Mini-Reviews Med Chem. 2011;11:438–45.CrossRef
33.
go back to reference Hughes TK, Fulep E, Juelich T, Smith EM, Stanton GJ. Modulation of immune responses by anabolic androgenic steroids. Int J Immunopharmacol. 1995;17:857–63.CrossRef Hughes TK, Fulep E, Juelich T, Smith EM, Stanton GJ. Modulation of immune responses by anabolic androgenic steroids. Int J Immunopharmacol. 1995;17:857–63.CrossRef
34.
go back to reference Chinen J, Shearer WT. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol. 2009;125(2 Suppl 2):S195–203.PubMedPubMedCentral Chinen J, Shearer WT. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol. 2009;125(2 Suppl 2):S195–203.PubMedPubMedCentral
35.
go back to reference Tan HP, Smaldone MC, Shapiro R. Immunosuppressive preconditioning or induction regimens: evidence to date. Drugs. 2006;66:1535–45.CrossRef Tan HP, Smaldone MC, Shapiro R. Immunosuppressive preconditioning or induction regimens: evidence to date. Drugs. 2006;66:1535–45.CrossRef
37.
go back to reference Sessa F, Salerno M, Di Mizio G, Bertozzi G, Messina G, Tomaiuolo B, et al. Anabolic androgenic steroids: searching new molecular biomarkers. Front Pharmacol. 2018;91321. Sessa F, Salerno M, Di Mizio G, Bertozzi G, Messina G, Tomaiuolo B, et al. Anabolic androgenic steroids: searching new molecular biomarkers. Front Pharmacol. 2018;91321.
38.
go back to reference Bafunno V, Santacroce R, Chetta M, Peyvandi F, Sessa F, Chinni E, et al. Polymorphic miRNA-mediated gene contribution to inhibitor development in haemophilia A. Haemophilia. 2012;18:1003–7.CrossRef Bafunno V, Santacroce R, Chetta M, Peyvandi F, Sessa F, Chinni E, et al. Polymorphic miRNA-mediated gene contribution to inhibitor development in haemophilia A. Haemophilia. 2012;18:1003–7.CrossRef
Metadata
Title
Immunodeficiency as a side effect of anabolic androgenic steroid abuse: a case of necrotizing myofasciitis
Authors
Giuseppe Bertozzi
Francesco Sessa
Francesca Maglietta
Luigi Cipolloni
Monica Salerno
Carmela Fiore
Palmira Fortarezza
Pietrantonio Ricci
Emanuela Turillazzi
Cristoforo Pomara
Publication date
01-12-2019
Publisher
Springer US
Published in
Forensic Science, Medicine and Pathology / Issue 4/2019
Print ISSN: 1547-769X
Electronic ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-019-00144-z

Other articles of this Issue 4/2019

Forensic Science, Medicine and Pathology 4/2019 Go to the issue